Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ayesha Rahman

Hand Surgery Jackson Heights, NY Medical Doctor

NPI 1891056453 CMS profile 844121

7206 Northern Blvd Fl 2, Jackson Heights, NY 11372

Open in the dashboard

General payments

$38,419

142 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ayesha Rahman of Jackson Heights, NY is reported in the CMS Open Payments database as having received $38,419 across 142 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $633 8
2024 General $13,542 43
2023 General $19,661 43
2022 General $3,953 25
2021 General $62 4
2020 General $47 3
2019 General $521 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ayesha Rahman
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Ayesha Rahman were reported at $633. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Ayesha Rahman Hand Surgery median Middle half National median
2019 $521 $383 $106–$1,905 $163
2020 $47 $172 $51–$1,268 $114
2021 $62 $263 $71–$1,591 $132
2022 $3,953 $336 $87–$1,938 $149
2023 $19,661 $233 $81–$1,114 $160
2024 $13,542 $258 $88–$1,203 $164
2025 $633 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Acumed LLC $36,300 106 payments
  2. Stryker Corporation $782 6 payments
  3. Skeletal Dynamics Inc $407 3 payments
  4. Gotham Surgical Solutions & Devices, Inc. $146 1 payment
  5. DePuy Synthes Sales Inc. $144 2 payments
  6. Horizon Therapeutics plc $144 10 payments
  7. AxoGen $134 1 payment
  8. Alafair Biosciences,Inc. $108 1 payment
  9. Flexion Therapeutics, Inc. $84 4 payments
  10. Orthofix Medical, Inc. $79 2 payments
  11. Other $92 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,372 4 payments
  2. Travel and Lodging $10,099 30 payments
  3. Consulting Fee $7,746 7 payments
  4. Food and Beverage $5,202 101 payments
Products named General payments · program years 2019–2025
  1. ACUMED Hand & Wrist $33,782 64 payments
  2. ACUMED Hand & Wrist $19,809 21 payments
  3. ACUMED Hand & Wrist $18,804 28 payments
  4. INnate Implant $11,192 17 payments
  5. ACUMED Screw & Pin $10,380 14 payments
  6. ACUMED Elbow $9,885 10 payments
  7. OsteoMed $8,890 8 payments
  8. ACUMED Elbow $8,650 9 payments
  9. ACUMED Hand & Wrist $3,327 9 payments
  10. InFrame Implant $2,329 14 payments
  11. Other $11,296 89 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

404

Median for Hand Surgery: 118

Drug cost

$3,632

Median for Hand Surgery: $615

Branded share of claims

0%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 145 $2,761
Meloxicam Generic 220 $677
Naproxen Generic 15 $135
Ibuprofen Generic 24 $59

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$61,664

Of which drugs: $19

Medicare patients

214

Average age 74

Services billed

612

150 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 46%
Ischemic heart disease 29%
Chronic kidney disease 24%
Depression 23%
Osteoporosis 23%
Heart failure 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 35 208 $19

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

142 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record